A detailed history of Bank Of Jackson Hole Trust transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of Jackson Hole Trust holds 3 shares of VRTX stock, worth $1,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$1,385
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$396.64 - $516.74 $1,189 - $1,550
3 New
3 $1.21 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bank Of Jackson Hole Trust Portfolio

Follow Bank Of Jackson Hole Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Jackson Hole Trust, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Jackson Hole Trust with notifications on news.